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Context. Several studies have shown a link between proinflammatory activity and the presence or deficit of some fatty acids.
Inflammation is associatedwith several diseases including diabetes.Objective. To characterize and compare the fatty acids profiles in
children with inaugural type 1 diabetes, diabetic children (at least 1 year after diagnosis), and healthy children.Design. Plasma fatty
acids profiles in childrenwith inaugural diabetes, childrenwith noninaugural diabetes, and controls, all of whomwere prepubescent
with a BMI < 85th percentile, were evaluated. Results. Omega-3 fatty acid levels were higher in recently diagnosed subjects with
diabetes than in controls. The ratio of omega-6/omega-3 fatty acids was higher in the control population. Omega-6 fatty acid levels
were higher in the nonrecent diabetic subjects than in the children with recently diagnosed diabetes, and the levels were higher in
the nonrecent diabetes group compared to the control group.Conclusion. Our findings showed higher levels of alpha-linolenic acid,
EPA, and DHA, as well as mono- and polyunsaturated fatty acids, in diabetic children. These findings reinforce the importance of
precocious nutritional attention and intervention in the treatment of diabetic children.
1. Introduction
Type 1 diabetes is an autoimmune disease triggered by
the destruction of pancreatic beta cells. It is usually pre-
ceded by the emergence of autoimmunity, including anti-
GAD antibodies (glutamine decarboxylase). Both genetic
and environmental factors contribute to the development of
the disease [1].
Several studies have demonstrated a link between proin-
flammatory activity and the presence or relative deficit of
some fatty acids [2, 3].Thus, a low level of omega-3 fatty acids,
which occurs frequently in western diets, appears to promote
an inflammatory response. In fact, higher intake of omega-
3 fatty acids and a high concentration of these fatty acids in
the erythrocyte membrane are associated with a lower risk of
developing pancreatic beta-autoimmunity [4].
It is also known that there is a relationship between
inflammatory activity and the presence of type 1 diabetes-
associated complications such as retinopathy or diabetic
nephropathy. A diet rich in omega-3 fatty acids appears
to be beneficial through the promotion of greater insulin
sensitivity and improved glucose metabolism [5]. These fatty
acids decrease inflammation by altering the transcription of
genes involved in the inflammatory response (e.g., NF-kB,
INF-𝛾) and by competing with the binding of omega-6 fatty
acids to enzymes involved in the synthesis of proinflam-
matory eicosanoids [6]. Eicosanoids are biologically active
lipid mediators that regulate inflammation [7] and include
prostaglandins, prostacyclins, thromboxanes, lipoxins, and
leukotrienes [8]. The presence of high levels of prostaglandin
E2 appears to promote the loss of beta cells and inhibits
beta cell proliferation. Prostaglandin E2 also reduces insulin
Hindawi
International Journal of Pediatrics
Volume 2017, Article ID 6424186, 5 pages
https://doi.org/10.1155/2017/6424186
2 International Journal of Pediatrics
Table 1: Characteristics of participants.
Type 1 diabetes New onset diabetes Controls
Number 23 6 12
M/F ratio 12/11 3/3 7/5
Age (years) 7.15 (4.0–9.7) 7.36 (3.9–9.7) 6.6 (3.6–10.3)
BMI (kg/m2) 17.03 16.94 16.97
Duration of disease (years) 3.29 (0.5–7.2)
HbA1c (%) 8.17 (6.3–10.8) 9.9 (8.2–11.9)
secretion and insulin sensitivity through its binding to the
EP3 receptor [9].
𝛼-Linolenic acid is the primary omega-3 fatty acid present
in western diets and is found especially in vegetables, namely,
in soy [1]. Eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA) are found in fat fish that is frequently consumed
in the Mediterranean diet.
Omega-6 fatty acids promote inflammation. The main
acid of this type in the western diet is linoleic acid, which is
present mainly in vegetable oils, and arachidonic acid, which
is derived from meat.
While the clinical follow-up of children and young people
with type 1 diabetes involves the periodic evaluation of
their lipid profile, namely, total cholesterol, HDL, LDL, and
triglycerides, the concentrations of different types of fatty
acids have not been investigated.
To address this gap in knowledge, the authors aimed
to study the differences between the fatty acid profiles in
children with inaugural type 1 diabetes, diabetic children (at
least 1 year after diagnosis), and healthy children.
2. Methods
2.1. Human Sample. Between 2012 and 2013, we obtained
plasma fatty acids profiles from prepubescent children with
inaugural diabetes and with a BMI < 85th percentile at the
time of their diagnosis (𝑁 = 8). Ages ranged from 4.8 to 9.6
years (average: 8.47). We also included diabetic children who
attended the Pediatric EndocrinologyUnit of S. Joa˜oHospital
(𝑁 = 34) whowere between 2.8 and 10.4 years of age (average:
7.06). Children were excluded if they had a BMI above the
85th percentile, were diagnosed less than six months prior to
enrolment, had other associated diseases, or were taking any
other medication. Children with a Tanner stage ≥ 2 were also
excluded.
The control population included children who were
scheduled to undergo planned surgical interventions, had
no chronic diseases, and were not taking any medication.
Childrenwith a BMI> 85th percentile or whowere pubescent
were also excluded. These children were between 3.5 and 8.6
years of age (average: 6.1) (Table 1).
The study was approved by the hospital’s ethics commit-
tee. Authorization and informed consent were obtained from
the parents of all the children participating in the study.
2.2. Chemicals and Reagents. Sodium hydroxide and anhy-
drous sodium sulfate were obtained from Pronalab (Lisbon,
Portugal); boron trifluoride in methanol (14% in methanol)
and butylated hydroxytoluene (BHT) (≥99%) were from
Sigma-Aldrich (St. Louis, USA); 𝑛-hexane (99%) was
from Merck (Darmstadt, Germany); methanol was from
VWR Chemicals Prolabo (Fontenay-sous-Bois, France);
and sodium chloride (99.5%) was from Panreac (Barcelona,
Spain).
2.3. Determination of Plasma Fatty Acids Profiles by Gas
Chromatography Coupled to a Flame Ionization Detector. To
analyze the plasma fatty acids profiles, the boiling point must
first be lowered which is achieved by the derivatization of the
fatty acids [10]. In this case, sodium methoxide (NaOMe) is
used as a catalyst to form fatty acid methyl esters (FAMEs)
[11] which have a lower boiling point.
The plasma samples were placed in tubes with 20𝜇g of
internal standard (C13:0), and then 5mL of NaOMe (0.5M)
was added, and the tube was vigorously shaken. The samples
were heated to 100∘C for 10min and cooled for 5min on
ice. After cooling, 5mL of boron trifluoride-methanol was
added to the samples, which were again heated to 100∘C for
30min and cooled for 5min on ice.Then, 600𝜇L of 𝑛-hexane
with butylated hydroxytoluene (BHT) (0.02%) was added to
prevent lipid oxidation.The tubes were vortexed, and 2mL of
sodium chloride was added; then, the tubes were centrifuged
for 10min at 2200 rpm.The top layer was retrieved and dried
with anhydrous sodium sulfate. Then, 100 𝜇L was removed
and evaporated to dryness with nitrogen and finally rediluted
in 75 𝜇L of 𝑛-hexane [12].
Gas chromatography analyses were performed using a
ShimadzuGC-2010 equippedwith a flame ionization detector
and a Shimadzu AOC-20i autoinjector. The separation of
FAMEs was carried out on an Agilent J&W Cp-Sil 88
capillary column (50m × 0.25mm ID, 0.20 𝜇m) from Santa
Clara, USA. The operating conditions were as follows: the
split–splitless injector was used in split mode with a split ratio
of 1 : 50. The injection volume of the sample was 1.5 𝜇L. The
injector and detector temperatures were kept at 250∘C and
270∘C, respectively.The temperature program was as follows:
initial temperature 120∘C for 5min, which was increased at
3∘C/min to 220∘C and held at this level for 10min (total
run time: 48min); carrier gas: He, 30mL/min; detector gas
flows: H
2
, 40mL/min; air, 400mL/min. Data acquisition and
processing were performed with Shimadzu software for GC
systems.
2.4. Statistical Analysis. Statistical analyses were performed
with the Statistical Package for the Social Sciences (SPSS
statistical software, version 21.0, IBM Corp., USA). The
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Table 2: Plasma fatty acids.
Plasma FA
NOD Diabetes (D) Controls (C) NPT
𝑛 Mean SD 𝑁 Mean SD 𝑛 Mean SD NOD versus D NOD versus C C versus D
𝑃 𝑃 𝑃
Sat. FA 8 35,12 3,33 34 31,77 2,87 10 34,45 1,39 0,009 0,897 0,004
Omega-3 8 4,37 1,05 34 4,21 0,98 10 3,76 0,52 0,44 0,043 0,085
Omega-6 8 34,82 4,18 34 39,11 3,85 10 34,97 2,87 0,012 0,829 0,001
LA/ALA 7 220,45 86,35 28 184,82 101,94 9 498,84 285,05 0,199 0,042 0,002
NOD: new onset diabetes; Sat. FA: saturated fatty acids; SD: standard deviation; NPT: nonparametric test.
Table 3: Plasma fatty acid profile.
Plasma fatty acid profile
New onset diabetes Diabetes Controls NPT
𝑛 Mean SD 𝑁 Mean SD 𝑛 Mean SD Nod versus D Nod versus C C versus D
𝑃 𝑃 𝑃
Butyric acid 8 1,55 2,31 34 0,78 1,18 10 1,19 0,74 0,199 0,515 0,058
Caproic acid 6 0.03 0.02 29 0.07 0.04 9 0.03 0.01 0.014 0.955 0.004
Lauric acid 7 0.14 0.11 11 0.06 0.02 9 0.10 0.07 0.056 0.408 0.056
Myristic acid 8 1.05 0.55 34 0.67 0.30 10 0.83 0.25 0.037 0.408 0.096
Pentadecanoic acid 8 0.28 0.12 32 0.29 0.26 10 0.29 0.14 0.415 0.762 0.358
Palmitic acid 8 23.82 2.36 34 21.01 1.71 10 22.99 1.48 0.001 0.515 0.002
Palmitoleic acid 8 1.71 0.80 34 1.03 0.38 10 1.75 0.44 0.022 0.515 0.0004
Heptadecanoic acid 8 0.29 0.07 34 0.25 0.07 10 0.24 0.05 0.114 0.068 0.710
Stearic acid 8 7.86 0.98 34 8.47 1.56 10 8.62 0.71 0.210 0.083 0.945
Oleic acid 8 22.92 2.52 34 22.35 4.87 10 24.04 1.67 0.320 0.315 0.031
Linoleic acid 8 26.82 3.55 34 30.72 3.67 10 27.87 3.00 0.012 0.573 0.041
𝛾-Linolenic acid 8 0.54 0.20 34 0.50 0.12 10 0.64 0.32 0.937 0.515 0.066
ALA 7 0.14 0.08 28 0.20 0.09 9 0.08 0.06 0.104 0.042 0.0002
Arachidonic acid 8 7.23 1.45 34 7.70 1.69 10 6.22 0.85 0.304 0.101 0.001
DHA 8 2.12 0.75 34 1.95 0.74 10 1.35 0.33 0.582 0.016 0.002
ALA: 𝛼-linolenic acid; NPT: nonparametric test.
acquired data (clinical, biological, and fatty acids profiles)
were divided into two different pairs: diabetic/not diabetic
and inaugural diabetic/not inaugural diabetic. Clinical and
biological data were reported as the mean and standard
deviation (SD), as well as median and respective interquartile
range (IQR), and the lipid profile data for these groups were
reported as the median and respective interquartile range
(IQR). The Mann–Whitney test was used to compare the
median of the fatty acid percentage between the groups. All
probabilities with𝑃 values< 0.05were regarded as significant.
3. Results
3.1. Plasmatic Fatty Acids Profile. Inaugural Diabetes versus
Noninaugural Diabetes. Significant differences between these
two groups of children were observed.There was a significant
difference in the presence of saturated fatty acids, long-chain
saturated fatty acids, palmitic acid, and palmitoleic acid, with
higher levels at the time of diagnosis. Moreover, we observed
higher levels of omega-6 fatty acids in diabetic children
(Table 2).
Inaugural Diabetes versus Controls.Childrenwith a recent
diagnosis of diabetes had higher levels of omega-3 fatty acids,
alpha-linolenic acid, and DHA. Healthy children from the
control population had a higher ratio of LA/ALA (linoleic
acid/alpha-linolenic acid).
Noninaugural Diabetes versus Controls. The EPA/AA
ratio (eicosapentaenoic acid/arachidonic acid) and the
amounts of saturated fatty acids, omega-9 fatty acids, cis-
monounsaturated fatty acids, saturated long-chain fatty acids,
palmitic acid, and palmitoleic acid were higher in the control
population.The diabetic children had higher levels of omega-
6 fatty acids, polyunsaturated fatty acids, cis-pentadecenoic
acid, heptadecenoic acid, linoleic acid, linolenic acid, and
arachidonic acid (Table 3).
4. Discussion
Contrary to findings from other studies, the levels of omega-3
fatty acids were higher in the recent diabetes group relative to
controls. However, other studies have found no relationship
between the presence of these fatty acids and diabetes [13].
The amount of omega-6 fatty acids was actually higher in the
control population. The content of fatty acids in the control
population, which was made up of healthy children with a
normal BMI, raises questions about the diet of these children.
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Table 4: Plasma lipid profile.
Plasma lipid profile New onset diabetes Diabetes Nonparametric test
𝑁 Min. Max. Mean SD 𝑛 Min. Max. Mean SD NOD versus D
Total cholesterol (mg/dl) 5 175.0 215.0 187.0 17.13 31 123.0 224.0 162.26 22.34 0.012
Total triglycerides (mg/dl) 5 50.0 81.0 62.8 12.28 30 31.0 118.0 59.43 20.92 0.477
HDL cholesterol (mg/dl) 5 80.0 150.0 107.8 27.22 30 52.0 135.0 91.7 19.16 0.321
LDL cholesterol (mg/dl) 5 49.0 87.0 66.6 13.59 31 21.0 75.0 58.1 11.09 0.282
We found that omega-6 levels were higher in the non-
recent diabetes group compared to the recent diabetes and
to the control groups. In addition, linoleic acid levels were
higher in the recent diabetes group. Kurotani et al. have
already described an inverse relationship between the levels
of C-peptide and this fatty acid [13].
An inhibitory effect of palmitic acid on the production
and metabolic action of insulin has been described [14].
Curiously, our results showed higher levels of this fatty acid
in the recent diabetes group.
Several studies have also shown a relationship between
elevated levels of palmitic and palmitoleic acids and low levels
of linolenic and linoleic acids with insulin resistance markers
[15–17].
It is interesting to note that the omega-6/omega-3 ratio
did not fall within the recommended values (3/1) in either
group (inaugural diabetes: 7.9/1; noninaugural diabetes: 9.2/1;
controls: 9.3/1) [18]. The polyunsaturated fatty acids were
more abundant in children with established diabetes, even
when compared to controls.Therewas an inverse relationship
with respect to saturated fatty acids and long-chain fatty
acids, which were lower in the children with diabetes.
Although many different fatty acids have statistically signif-
icant relationships between these three groups, some seem to
detach due to very low levels of alpha-linolenic acid in either
the control or the inaugural diabetes group. Furthermore,
curiously, EPA andDHAweremore abundant in the children
with diabetes compared with the control population and the
inaugural diabetes group.
All of these differences were found in children with
identical total triglycerides, though cholesterol levels were
higher at the time diabetes was diagnosed. The overall lipid
profile was not assessed in the controls (Table 4).
5. Conclusion
Our results showed that children with diabetes had higher
levels of alpha-linolenic acid, EPA, and DHA, as well as
mono- and polyunsaturated fatty acids. This observation
is attributed to pharmacological therapy and nutritional
management of these children. Indeed, knowing the crucial
role of food in the treatment and control of type 1 diabetes
is part of the follow-up of these patients, which is supposed
to review and guide them from a nutritional point of view.
Particular emphasis should be placed on the importance of
maintaining a healthy diet, with an adequate component
of fruits and vegetables as well as diversification of animal
sources. Note that the fatty acid profile of diabetic children
appears to be healthier than that of children in their inaugural
episode as well as healthy children, leading the authors to
highlight the importance of early nutritional intervention.
It is also noted that “healthy” Portuguese children show
high levels of saturated fatty acids, as well as an omega-
6/omega-3 ratio that is much higher than recommended.
Even though we live in a country where, ideally, a so-called
Mediterranean diet is practiced, the authors questionwhether
the younger members of our society are actually consuming
this type of diet.
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